These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33864052)

  • 21. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Jentsch PC; Anand M; Bauch CT
    Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accessing the syndemic of COVID-19 and malaria intervention in Africa.
    Shi B; Zheng J; Xia S; Lin S; Wang X; Liu Y; Zhou XN; Liu J
    Infect Dis Poverty; 2021 Jan; 10(1):5. PubMed ID: 33413680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021.
    Borchering RK; Viboud C; Howerton E; Smith CP; Truelove S; Runge MC; Reich NG; Contamin L; Levander J; Salerno J; van Panhuis W; Kinsey M; Tallaksen K; Obrecht RF; Asher L; Costello C; Kelbaugh M; Wilson S; Shin L; Gallagher ME; Mullany LC; Rainwater-Lovett K; Lemaitre JC; Dent J; Grantz KH; Kaminsky J; Lauer SA; Lee EC; Meredith HR; Perez-Saez J; Keegan LT; Karlen D; Chinazzi M; Davis JT; Mu K; Xiong X; Pastore Y Piontti A; Vespignani A; Srivastava A; Porebski P; Venkatramanan S; Adiga A; Lewis B; Klahn B; Outten J; Schlitt J; Corbett P; Telionis PA; Wang L; Peddireddy AS; Hurt B; Chen J; Vullikanti A; Marathe M; Healy JM; Slayton RB; Biggerstaff M; Johansson MA; Shea K; Lessler J
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):719-724. PubMed ID: 33988185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
    Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
    Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa.
    Reddy KP; Fitzmaurice KP; Scott JA; Harling G; Lessells RJ; Panella C; Shebl FM; Freedberg KA; Siedner MJ
    Nat Commun; 2021 Oct; 12(1):6238. PubMed ID: 34716349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.
    Liu Y; Morgenstern C; Kelly J; Lowe R; ; Jit M
    BMC Med; 2021 Feb; 19(1):40. PubMed ID: 33541353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies.
    Li CX; Noreen S; Zhang LX; Saeed M; Wu PF; Ijaz M; Dai DF; Maqbool I; Madni A; Akram F; Naveed M; Li JH
    Biomed Pharmacother; 2022 Feb; 146():112550. PubMed ID: 34959116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting COVID-19 pandemic waves including vaccination data with deep learning.
    Begga A; Garibo-I-Orts Ò; de María-García S; Escolano F; Lozano MA; Oliver N; Conejero JA
    Front Public Health; 2023; 11():1279364. PubMed ID: 38162619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 Variants, Vaccines, and Host Immunity.
    Mistry P; Barmania F; Mellet J; Peta K; Strydom A; Viljoen IM; James W; Gordon S; Pepper MS
    Front Immunol; 2021; 12():809244. PubMed ID: 35046961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The way of SARS-CoV-2 vaccine development: success and challenges.
    Dong Y; Dai T; Wang B; Zhang L; Zeng LH; Huang J; Yan H; Zhang L; Zhou F
    Signal Transduct Target Ther; 2021 Nov; 6(1):387. PubMed ID: 34753918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout.
    Djaafara BA; Whittaker C; Watson OJ; Verity R; Brazeau NF; Widyastuti ; Oktavia D; Adrian V; Salama N; Bhatia S; Nouvellet P; Sherrard-Smith E; Churcher TS; Surendra H; Lina RN; Ekawati LL; Lestari KD; Andrianto A; Thwaites G; Baird JK; Ghani AC; Elyazar IRF; Walker PGT
    BMC Med; 2021 Jun; 19(1):146. PubMed ID: 34144715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study.
    Coudeville L; Jollivet O; Mahé C; Chaves S; Gomez GB
    PLoS One; 2021; 16(4):e0250797. PubMed ID: 33909687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants.
    Sah P; Vilches TN; Moghadas SM; Fitzpatrick MC; Singer BH; Hotez PJ; Galvani AP
    EClinicalMedicine; 2021 May; 35():100865. PubMed ID: 33937735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment.
    Min KD; Tak S
    Epidemiol Health; 2021; 43():e2021040. PubMed ID: 34082498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of booster vaccination and ongoing viral evolution in seasonal circulation of SARS-CoV-2.
    Kraay ANM; Gallagher ME; Ge Y; Han P; Baker JM; Koelle K; Handel A; Lopman BA
    J R Soc Interface; 2022 Sep; 19(194):20220477. PubMed ID: 36067790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of intensity and duration of non-pharmacological interventions and implementation of vaccination with COVID-19 infection, death, and excess mortality: Natural experiment in 22 European countries.
    Zhou F; Hu TJ; Zhang XY; Lai K; Chen JH; Zhou XH
    J Infect Public Health; 2022 May; 15(5):499-507. PubMed ID: 35429788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.